StayCurrentMD · Transitioning Paediatric Empyema Management: Comparative Efficacy Analysis of tPA and DNase versus Surgical Interventions
Article1 min read·Published Nov 2025

Transitioning Paediatric Empyema Management: Comparative Efficacy Analysis of tPA and DNase versus Surgical Interventions

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Nov 2025 · 1 min read

In brief

In brief

This study compares non-surgical fibrinolytic treatment using tPA and DNase combination against surgical approaches (VATS and thoracotomy) for managing paediatric empyema. The analysis addresses treatment efficacy, helping clinicians optimize intervention strategies for children with complicated pleural infections.

  • tPA/DNase fibrinolytic therapy offers a non-surgical alternative for paediatric empyema management
  • Comparative efficacy data can guide treatment selection between medical and surgical approaches
  • Empyema treatment choice impacts both clinical outcomes and healthcare system costs
  • VATS and thoracotomy remain important surgical options when fibrinolysis is insufficient

Written by the GCMD Library team from the article.

Empyema significantly impacts paediatric morbidity and imposes a financial burden on healthcare systems. This study evaluates the efficacy of tissue plasminogen activator (tPA) and dornase alpha (DNase) combination in fibrinolytic therapy compared with surgical interventions (VATS/thoracotomy) in children with empyema.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →